387 related articles for article (PubMed ID: 28096078)
1. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
Valencia WM; Florez H
BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
Tremolada G; Lattanzio R; Mazzolari G; Zerbini G
Am J Cardiovasc Drugs; 2007; 7(6):393-8. PubMed ID: 18076206
[TBL] [Abstract][Full Text] [Related]
4. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
Yoo H; Park I; Kim DJ; Lee S
Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
[TBL] [Abstract][Full Text] [Related]
6. Research digest: progress in microvascular complications.
Sattar N; Preiss D
Lancet Diabetes Endocrinol; 2018 Feb; 6(2):93. PubMed ID: 29413165
[No Abstract] [Full Text] [Related]
7. Aldose reductase inhibitors and diabetic complications.
Tomlinson DR; Willars GB; Carrington AL
Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
[TBL] [Abstract][Full Text] [Related]
8. [Late complications of diabetes mellitus type II (non-insulin- dependent)].
Czech A
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():23-8. PubMed ID: 8516200
[No Abstract] [Full Text] [Related]
9. [Diabetic complication: definition and classification].
Nishizawa Y
Nihon Rinsho; 1991 Feb; 49 Suppl():3-8. PubMed ID: 2033818
[No Abstract] [Full Text] [Related]
10. Microvascular Complications and Prevalence of Nocturia in Japanese Patients With Type 2 Diabetes Mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Urology; 2016 Jul; 93():147-51. PubMed ID: 26995392
[TBL] [Abstract][Full Text] [Related]
11. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes.
Bonapace S; Rossi A; Lipari P; Bertolini L; Zenari L; Lanzoni L; Canali G; Molon G; Mantovani A; Zoppini G; Bonora E; Barbieri E; Targher G
J Diabetes Complications; 2015 Aug; 29(6):822-8. PubMed ID: 26050564
[TBL] [Abstract][Full Text] [Related]
12. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
Gaede PH; Jepsen PV; Parving HH; Pedersen OB
Ugeskr Laeger; 1999 Jul; 161(30):4277-85. PubMed ID: 10439688
[TBL] [Abstract][Full Text] [Related]
13. Insulin-dependent diabetes mellitus: pathophysiology.
Gerich JE
Mayo Clin Proc; 1986 Oct; 61(10):787-91. PubMed ID: 3528691
[TBL] [Abstract][Full Text] [Related]
14. Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review.
Czupryniak L; Joshi SR; Gogtay JA; Lopez M
Expert Opin Pharmacother; 2016 Aug; 17(11):1463-73. PubMed ID: 27267786
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients.
Jensen T; Deckert T
Horm Metab Res Suppl; 1992; 26():68-70. PubMed ID: 1490695
[TBL] [Abstract][Full Text] [Related]
16. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
Boel E; Selmer J; Flodgaard HJ; Jensen T
J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
[TBL] [Abstract][Full Text] [Related]
17. Microvascular complications of diabetes.
He Z; King GL
Endocrinol Metab Clin North Am; 2004 Mar; 33(1):215-38, xi-xii. PubMed ID: 15053904
[No Abstract] [Full Text] [Related]
18. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
Reichard P; Nilsson BY; Rosenqvist U
N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
[TBL] [Abstract][Full Text] [Related]
19. Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.
Gibbons CH; Goebel-Fabbri A
Curr Diab Rep; 2017 Jul; 17(7):48. PubMed ID: 28526993
[TBL] [Abstract][Full Text] [Related]
20. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Kaabi YA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
